Clinical Characteristics of Patients with Type 2 Diabetes Mellitus Receiving a Primary Total Knee or Hip Arthroplasty

Table 2

Common comorbidities related to type 2 diabetes mellitus (T2DM).

	TKA		THA		T2DM, no OA
	T2DM	Non-T2DM	T2DM	Non-T2DM
Urinary, % ()	3.70 (2)^a	0 (0)^a	11.5 (3)^a	0 (0)^b	—
Cardiovascular, % ()	31.5 (17)^a,c	1.2 (2)^a	19.2 (5)^b,c	1.8 (2)^b	44.8 (39)^c
Nephropathy, % ()	18.5 (10)^a,c	1.2 (2)^a	3.80 (1)^c	2.70 (3)	39.1 (34)^c
Hypertension, % ()	81.5 (44)^a	43.2 (73)^a	73.1 (19) ^c	46 (51)	87.4 (76)^c
Dyslipidemia, % ()	61.1 (33)^a	29 (49)^a	50.0 (13)^b	20.7 (23)^b	49.4 (43)
Atherosclerosis, % ()	9.3 (5)^c	5.3 (9)	15.4 (4)^c	9 (10)	33.3 (29)^c
Hypothyroid, % ()	14.8 (8)	7.1 (12)	15.4 (4)	7.2 (8)	—
Peripheral neuropathy, % ()	18.5 (10)^a	2.4 (4)^a	42.3 (11)^b,c	5.4 (6)^b	13.8 (12)^c

— indicates that data is unavailable for the T2DM with no OA group.  = number of patients; THA = total hip arthroplasty; TKA = total knee arthroplasty; ^aSignificant between T2DM versus non-T2DM for TKA cohort; ^bSignificant between T2DM versus non-T2DM for THA group; ^cSignificant between T2DM groups or arthroplasty versus no OA.